Cargando…
Safety of PPAR Agonists
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632164/ https://www.ncbi.nlm.nih.gov/pubmed/21525458 http://dx.doi.org/10.2337/dc11-s233 |
_version_ | 1782266852240523264 |
---|---|
author | Home, Philip |
author_facet | Home, Philip |
author_sort | Home, Philip |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3632164 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-36321642013-04-24 Safety of PPAR Agonists Home, Philip Diabetes Care Diabetes Treatments American Diabetes Association 2011-05 2011-04-22 /pmc/articles/PMC3632164/ /pubmed/21525458 http://dx.doi.org/10.2337/dc11-s233 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Diabetes Treatments Home, Philip Safety of PPAR Agonists |
title | Safety of PPAR Agonists |
title_full | Safety of PPAR Agonists |
title_fullStr | Safety of PPAR Agonists |
title_full_unstemmed | Safety of PPAR Agonists |
title_short | Safety of PPAR Agonists |
title_sort | safety of ppar agonists |
topic | Diabetes Treatments |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632164/ https://www.ncbi.nlm.nih.gov/pubmed/21525458 http://dx.doi.org/10.2337/dc11-s233 |
work_keys_str_mv | AT homephilip safetyofpparagonists |